Your browser doesn't support javascript.
loading
Implementation of South Africa's Central Chronic Medicine Dispensing and Distribution Program for HIV Treatment: A Qualitative Evaluation.
Bogart, Laura M; Shazi, Zinhle; MacCarthy, Sarah; Mendoza-Graf, Alexandra; Wara, Nafisa J; Zionts, Dani; Dube, Nduduzo; Govere, Sabina; Bassett, Ingrid V.
Afiliación
  • Bogart LM; RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA. lbogart@rand.org.
  • Shazi Z; AIDS Healthcare Foundation, Durban, South Africa.
  • MacCarthy S; RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
  • Mendoza-Graf A; Department of Health Behavior, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Wara NJ; RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
  • Zionts D; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Dube N; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Govere S; AIDS Healthcare Foundation, Durban, South Africa.
  • Bassett IV; AIDS Healthcare Foundation, Durban, South Africa.
AIDS Behav ; 26(8): 2600-2612, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35122215
We used the Practical, Robust Implementation and Sustainability Model to evaluate implementation of South Africa's Central Chronic Medicine Dispensing and Distribution (CCMDD) program, a differentiated service delivery program which allows clinically stable HIV-positive patients to receive antiretroviral therapy refills at clinic- or community-based pick-up points. Across ten clinics, we conducted 109 semi-structured interviews with stakeholders (pick-up point staff, CCMDD service providers and administrators) and 16 focus groups with 138 patients. Participants had highly favorable attitudes and said CCMDD decreased stigma concerns. Patient-level barriers included inadequate education about CCMDD and inability to get refills on designated dates. Organizational-level barriers included challenges with communication and transportation, errors in medication packaging and tracking, rigid CCMDD rules, and inadequate infrastructure. Recommendations included: (1) provide patient education and improve communication around refills (at the patient level); (2) provide dedicated space and staff, and ongoing training (at the organizational/clinic level); and (3) allow for prescription renewal at pick-up points and less frequent refills, and provide feedback to clinics (at the CCMDD program level).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH Tipo de estudio: Evaluation_studies / Guideline / Qualitative_research / Sysrev_observational_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: AIDS Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH Tipo de estudio: Evaluation_studies / Guideline / Qualitative_research / Sysrev_observational_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: AIDS Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos